Fundz

Rgenta Therapeutics, Inc. reported raising $6 Million in an initial SEC Form D filing, from an offering of $20 Million

PRIVATEFeb 05, 2020$6M of $20M raised

Amount Raised

$6 Million

$6 Million sold, per SEC Form D (first sale Feb 5, 2020)

Round Type

Venture

CambridgeOtherBiotechnologyHealth CareVenture Capital

Quick answer

Rgenta Therapeutics, Inc. raised $6 Million in a funding round, dated February 5, 2020. Rgenta Therapeutics, Inc. is based in Cambridge, Massachusetts, United States.

How much did Rgenta Therapeutics, Inc. raise?
Rgenta Therapeutics, Inc. raised $6 Million in a funding round on February 5, 2020.
What does Rgenta Therapeutics, Inc. do?
Rgenta Therapeutics is developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders.
Where is Rgenta Therapeutics, Inc. based and how big is it?
Rgenta Therapeutics, Inc. is based in Cambridge, Massachusetts, United States. Fundz records about 33 employees.
Who are the decision-makers at Rgenta Therapeutics, Inc?
Fundz holds 1 contact at Rgenta Therapeutics, Inc., including the Senior Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Venture Capital and Biotechnology around the same time

Companies in the same sectors as Rgenta Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • ReCode Therapeutics raised $27M on March 20, 2020.
  • Design Therapeutics, Inc. raised $46M on March 20, 2020.
  • Lyell Immunopharma raised $493M on March 20, 2020.
  • Fractyl Health raised $45M on March 19, 2020.
  • DermTech, Inc. raised $65M on March 16, 2020.
  • Aclarion raised $1.4M (Seed) on March 12, 2020.

Who to call at Rgenta Therapeutics, Inc., and when

A new round usually means Rgenta Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Rgenta Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Rgenta Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Rgenta Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Rgenta Therapeutics, Inc.

Location

700 Main Street

Cambridge, Massachusetts, United States

About

Rgenta Therapeutics is developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders. Our proprietary platform mines the massive genomics data to identify targetable RNA processing events and design small-molecule glues to modulate the interactions among the spliceosome, regulatory proteins, and RNAs. Our lead programs and unique approach are unlocking the therapeutic potential of historically undruggable targets in human diseases. Learn more at http://www.rgentatx.com

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Rgenta Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsSamuel, Senior Director hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Rgenta Therapeutics, Inc.'s next move

See what Strategic adds

Rgenta Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.